Hope for Alzheimer’s patients? Dipeptide blocks the formation of toxic amyloid β-peptide aggregates in mice

Dec 04, 2008

(PhysOrg.com) -- Alzheimer's disease is the primary cause of age-related dementia. About 15 million people are affected by this neurodegenerative disease worldwide. It has so far not been possible to combat the causes of Alzheimer’s disease. Israeli researchers have now developed a novel approach for treatment. As they report in the journal Angewandte Chemie, the new drug, a molecule made from two nonphysiological amino acids, improves the cognitive abilities of mice with Alzheimer’s and reduces the amyloid plaques in their brains.

Many years before clinical symptoms appear, threadlike deposits of incorrectly folded amyloid β-peptides, known as plaques, form in the brains of Alzheimer’s patients. It was previously assumed that these plaques initiate the degeneration of nerve cells; however, more recent discoveries indicate that smaller, soluble aggregates of the amyloid-forming peptide are the actual cause for the loss of learning and memory functions.

These oligomers of about twelve peptide units have a strong toxic effect on nerve cells. The new therapeutic approach taken by researchers working with Ehud Gazit at the University of Tel Aviv aims to block the formation of these toxic oligomers.

A drug molecule was rationally designed that contains an aromatic amino acid and a β-sheet breaker. Aromatic side-groups play a key role in the aggregation of amyloid-forming peptides; the drug should thus bind to the aromatic core of the β-amyloid peptide through its aromatic element. Also, in amyloid aggregates, the proteins adopt the form of β-sheets that are folded like accordions; the drug should thus be a β-breaker, a molecule that prevents proteins from folding into β-sheets. In addition, the molecule must be small so that it can be absorbed by the digestive tract after oral ingestion. It must also not be rapidly degraded by the body and must be nontoxic.

The small dipeptide—a molecule made of two amino acids—developed by Gazit’s team meets all of these requirements: the nonphysiological amino acid α-aminoisobutyric acid acts as a β-breaker, and the second amino acid, D-tryptophan, contains an indole group, which is an effective binder of aromatics. At the same time, D-tryptophan stabilizes the dipeptide, because D-amino acids are broken down more slowly in the body than are the physiological L-amino acids.

When genetically altered mice with Alzheimer’s disease are treated with the dipeptide, their disrupted cognitive functions normalize. A significant decrease in the concentration of amyloid-forming β-peptides and in the size of the plaques was found in the brains of these mice.

Citation: Ehud Gazit, Cognitive-Performance Recovery of Alzheimer's Disease Model Mice by Modulation of Early Soluble Amyloidal Assemblies, Angewandte Chemie International Edition, doi: 10.1002/anie.200802123

Provided by Wiley

Explore further: Oat breakfast cereals may contain a common mold-related toxin

add to favorites email to friend print save as pdf

Related Stories

Gently unfolding proteins to watch them refold

Jun 07, 2010

(PhysOrg.com) -- How does a protein chain fold into the same 3-D shape each time and not something disfunctional or dangerous? A new study shows that the first fold is critical. The finding ...

Blood test identifies women at risk from Alzheimer's

Nov 06, 2009

Middle-aged women with high levels of a specific amino acid in their blood are twice as likely to suffer from Alzheimer's many years later, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden. ...

Recommended for you

Oat breakfast cereals may contain a common mold-related toxin

Feb 25, 2015

Oats are often touted for boosting heart health, but scientists warn that the grain and its products might need closer monitoring for potential mold contamination. They report in ACS' Journal of Agricultural and Food Chemistry that s ...

NETL invents improved oxygen carriers

Feb 24, 2015

One of the keys to the successful deployment of chemical looping technologies is the development of affordable, high performance oxygen carriers. One potential solution is the naturally-occurring iron oxide, ...

Research could make blue jeans green

Feb 23, 2015

Who doesn't like blue jeans? They're practically wrinkle-proof. The indigo dye that provides their distinctive color holds up to detergents, but ages into that soft, worn look. No wonder the average American ...

Novel electrode boosts green hydrogen research

Feb 20, 2015

Scientists from the National Physical Laboratory (NPL) have developed a novel reference electrode, and are working with hydrogen energy system manufacturer ITM Power to aid the development of hydrogen production ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

gmurphy
5 / 5 (1) Dec 05, 2008
wow, excellent work. I hope these findings extend to humans.
tkjtkj
not rated yet Dec 05, 2008
Very interesting!
And just how did they produce the
genetically-engineered mice? did
they interbreed mice that had
plaques by brain biopsy? or did
they gather mice from the forest
that appeared lost?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.